Drug intelligence / Profile preview

medazepam

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Medazepam is a long‐acting benzodiazepine derivative used primarily for its anxiolytic, sedative, anticonvulsant, and skeletal muscle relaxant properties. It acts as a prodrug that is metabolized to nordazepam and other active benzodiazepines, contributing to its prolonged therapeutic effect. Medazepam enhances inhibitory neurotransmission in the central nervous system by allosteric modulation of the GABA(A) receptor complex, increasing the effect of gamma‐aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. This results in reduced neuronal excitability and produces calming effects useful for treating anxiety disorders. It may also be prescribed for insomnia related to anxiety or stress and has been used off-label for conditions such as muscle spasms or certain gastrointestinal disorders when combined with other agents[1][2][3][5][6].

Brand names
RudotelResmitNiveltonEnobrinMedazinAzepamidNobriumTranquirax (combination with bevonium)RaporanAnsilanMezapam
Other names
medazepam
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on medazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on medazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call